SEARCH

SEARCH BY CITATION

References

  • Asai M., Yagishita S., Iwata N., Saido T. C., Ishiura S. and Maruyama K. (2011) An alternative metabolic pathway of amyloid precursor protein C-terminal fragments via cathepsin B in a human neuroglioma model. FASEB J. 10, 37203730.
  • Bauer C., Pardossi-Piquard R., Dunys J., Roy M. and Checler F. (2011) γ-Secretase-Mediated Regulation of Neprilysin: Influence of Cell Density and Aging and Modulation by Imatinib. J. Alzheimers Dis. 27, 511520.
  • Beckett C., Nalivaeva N. N., Belyaev N. D. and Turner A. J. (2012) Nuclear signalling by membrane protein intracellular domains: the AICD enigma. Cell. Signal. 24, 402409.
  • Belyaev N. D., Nalivaeva N. N., Makova N. Z. and Turner A. J. (2009) Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep. 10, 94100.
  • Belyaev N. D., Kellett K. A., Beckett C., Makova N. Z., Revett T. J., Nalivaeva N. N., Hooper N. M. and Turner A. J. (2010) The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a β-secretase-dependent pathway. J. Biol. Chem. 285, 4144341454.
  • Bertrand E., Brouillet E., Caillé I., Bouillot C., Cole G. M., Prochiantz A. and Allinquant B. (2001) A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo. Mol. Cell. Neurosci. 18, 503511.
  • Brouillette J., Caillierez R., Zommer N., Alves-Pires C., Benilova I., Blum D., De Strooper B. and Buée L. (2012) Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1-42 oligomers are revealed in vivo by using a novel animal model. J. Neurosci. 32, 78527861.
  • Buxbaum J. N., Ye Z., Reixach N., Friske L., Levy C., Das P., Golde T., Masliah E., Roberts A. R. and Bartfai T. (2008) Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity. Proc. Natl Acad. Sci. USA 105, 26812686.
  • Cao X. and Südhof T. C. (2001) A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115120.
  • Carraro-Lacroix L. R., Jaumouillé V., Fairn G. D. and Grinstein S. (2011) A weak base-generating system suitable for selective manipulation of lysosomal pH. Traffic 12, 14901500.
  • Chakrabarti A., Chatterjee A., Sengupta M.B., Chattopadhyay P. and Mukhopadhyay D. (2013) Altered levels of amyloid precursor protein intracellular domain-interacting proteins in Alzheimer disease. Alzheimer Dis. Assoc. Disord. [Epub ahead of print]
  • Cupers P., Orlans I., Craessaerts K., Annaert W. and De Strooper B. (2001) The amyloid precursor protein (APP)-cytoplasmic fragment generated by γ-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture. J. Neurochem. 78, 11681178.
  • Dovey O. M., Foster C. T. and Cowley S. M. (2010) Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc. Natl Acad. Sci. USA 107, 82428247.
  • Du J., Cho P. Y., Yang D. T. and Murphy R. M. (2012) Identification of β-amyloid-binding sites on transthyretin. Protein Eng. Des. Sel. 25, 337345.
  • Edbauer D., Willem M., Lammich S., Steiner H. and Haass C. (2002) Insulin-degrading enzyme rapidly removes the β-amyloid precursor protein intracellular domain (AICD). J. Biol. Chem. 277, 1338913393.
  • Eisele Y. S., Baumann M., Klebl B., Nordhammer C., Jucker M. and Kilger E. (2007) Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-β degrading enzyme neprilysin. Mol. Biol. Cell 18, 35913600.
  • Fraering P. C., Ye W., LaVoie M. J., Ostaszewski B. L., Selkoe D. J. and Wolfe M. S. (2005) γ-Secretase substrate selectivity can be modulated directly via interaction with a nucleotide-binding site. J. Biol. Chem. 280, 4198741996.
  • Ghosal K., Vogt D. L., Liang M., Shen Y., Lamb B. T. and Pimplikar S. W. (2009) Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc. Natl Acad. Sci. USA 106, 1836718372.
  • Glenner G. G. and Wong C. W. (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885890.
  • Goate A. and Hardy J. (2012) Twenty years of Alzheimer's disease-causing mutations. J. Neurochem. 120(Suppl 1), 38.
  • Gordon A. H., Hart P. D. and Young M. R. (1980) Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature 286, 7980.
  • Gregory G. C. and Halliday G. M. (2005) What is the dominant Aβ species in human brain tissue? A review. Neurotox. Res. 7, 2941.
  • Grimm M. O., Zinser E. G., Grösgen S. et al. (2012) Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism. PLoS ONE 7, e34095.
  • Hansson S. F., Andréasson U., Wall M., Skoog I., Andreasen N., Wallin N. A., Zetterberg H. and Blennow K. (2009) Reduced levels of amyloid-β-binding proteins in cerebrospinal fluid from Alzheimer's disease patients. J. Alzheimers Dis. 16, 389397.
  • Hardy J. (2009) The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J. Neurochem. 110, 11291134.
  • Hardy J. A. and Higgins G. A. (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184185.
  • Hicks D. A., Makova N. Z., Gough M., Parkin E. T., Nalivaeva N. N. and Turner A. J. (2013) The amyloid precursor protein represses expression of acetylcholinesterase in neuronal cell lines. J. Biol. Chem. 288, 2603926051.
  • Hong Y., Beckett C., Belyaev N. D. and Turner A. J. (2011) The impact of amyloid precursor protein signalling and histone deacetylase inhibition on neprilysin expression in human prostate cells. Int. J. Cancer 130, 775786.
  • Huysseune S., Kienlen-Campard P., Hébert S., Tasiaux B., Leroy K., Devuyst O., Brion J. P., De Strooper B. and Octave J. N. (2009) Epigenetic control of aquaporin 1 expression by the amyloid precursor protein. FASEB J. 23, 41584167.
  • Iwata N., Takaki Y., Fukami S., Tsubuki S. and Saido T. C. (2002) Region-specific reduction of A β-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J. Neurosci. Res. 70, 493500.
  • Jonsson T., Atwal J. K., Steinberg S. et al. (2012) A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488, 9699.
  • Kim H. S., Kim E. M., Lee J. P. et al. (2003) C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3β expression. FASEB J. 17, 19511953.
  • Koh Y. H., von Arnim C. A., Hyman B. T., Tanzi R. E. and Tesco G. (2005) BACE is degraded via the lysosomal pathway. J. Biol. Chem. 280, 3249932504.
  • Leissring M. A. (2008) The AβCs of Aβ-cleaving proteases. J. Biol. Chem. 283, 2964529649.
  • Li H., Wang B., Wang Z., Guo Q., Tabuchi K., Hammer R. E., Südhof T. C. and Zheng H. (2010) Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP. Proc. Natl Acad. Sci. USA 107, 1736217367.
  • Li X., Masliah E., Reixach N. and Buxbaum J. N. (2011) Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective? J. Neurosci. 31, 1248312490.
  • Marambaud P. and Robakis N. K. (2005) Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation. Genes Brain. Behav. 4, 134146.
  • Müller T., Concannon C. G., Ward M. W., Walsh C. M., Tirniceriu A. L., Tribl F., Kögel D., Prehn J. H. and Egensperger R. (2007) Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol. Biol. Cell 18, 201210.
  • Müller T., Loosse C., Schrötter A., Schnabel A., Helling S., Egensperger R. and Marcus K. (2011) The AICD interacting protein DAB1 is up-regulated in Alzheimer frontal cortex brain samples and causes deregulation of proteins involved in gene expression changes. Curr. Alzheimer Res. 8, 573582.
  • Nalivaeva N. N. and Turner A. J. (2013) The amyloid precursor protein: a biochemical enigma in brain development, function and disease. FEBS Lett. 587, 20462054.
  • Nalivaeva N. N., Beckett C., Belyaev N. D. and Turner A. J. (2012a) Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease? J. Neurochem. 120(Suppl 1), 167185.
  • Nalivaeva N. N., Belyaev N. D., Lewis D. I., Pickles A. R., Makova N. Z., Bagrova D. I., Dubrovskaya N. M., Plesneva S. A., Zhuravin I. A. and Turner A. J. (2012b) Effect of sodium valproate administration on brain neprilysin expression and memory in rats. J. Mol. Neurosci. 46, 569577.
  • Netzer W. J., Dou F., Cai D., Veach D., Jean S., Li Y., Bornmann W. G., Clarkson B., Xu H. and Greengard P. (2003) Gleevec inhibits β-amyloid production but not Notch cleavage. Proc. Natl Acad. Sci. USA 100, 1244412449.
  • Nunan J., Shearman M. S., Checler F., Cappai R., Evin G., Beyreuther K., Masters C. L. and Small D. H. (2001) The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from γ-secretase. Eur. J. Biochem. 268, 53295336.
  • Octave J. N., Pierrot N., Ferao Santos S., Nalivaeva N. N. and Turner A. J. (2013) From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein. J. Neurochem. 126, 183190.
  • Pardossi-Piquard R. and Checler F. (2012) The physiology of the β-amyloid precursor protein intracellular domain AICD. J. Neurochem. 120(Suppl 1), 109124.
  • Pardossi-Piquard R., Petit A., Kawarai T. et al. (2005) Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of βAPP and APLP. Neuron 46, 541554.
  • Passer B., Pellegrini L., Russo C., Siegel R. M., Lenardio M. J., Schettini G., Bachmann M., Tabaton M. and D'Adamio L. (2000) Generation of an apoptotic intracellular peptide by γ-secretase cleavage of Alzheimer's amyloid β protein precursor. J. Alzheimer's Dis. 2, 289301.
  • Pelzel H. R., Schlamp C. L. and Nickells R. W. (2010) Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis. BMC Neurosci. 11, 62.
  • Pierrot N., Tyteca D., D'auria L. et al. (2013) Amyloid precursor protein controls cholesterol turnover needed for neuronal activity. EMBO Mol. Med. 5, 608625.
  • Pimplikar S. W., Nixon R. A., Robakis N. K., Shen J. and Tsai L. H. (2010) Amyloid-independent mechanisms in Alzheimer's disease pathogenesis. J. Neurosci. 30, 1494614954.
  • Relton J. M., Gee N. S., Matsas R., Turner A. J. and Kenny A. J. (1983) Purification of endopeptidase-24.11 (‘enkephalinase’) from pig brain by immunoadsorbent chromatography. Biochem. J. 215, 519523.
  • von Rotz R. C., Kohli B. M., Bosset J., Meier M., Suzuki T., Nitsch R. M. and Konietzko U. (2004) The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J. Cell Sci. 117, 44354448.
  • Ryan K. A. and Pimplikar S. W. (2005) Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J. Cell Biol. 171, 327335.
  • Saido T. and Leissring M. A. (2012) Proteolytic degradation of amyloid β-protein. Cold Spring Harb. Perspect. Med. 2, a006379.
  • Schwarzman A. L., Gregoti L., Vitek M. P. et al. (1994) Transthyretin sequesters amyloid β protein and prevents amyloid formation. Proc. Natl Acad. Sci. USA 91, 83688372.
  • Selkoe D. J. (2012) Preventing Alzheimer's disease. Science 337, 14881492.
  • Selkoe D. and Kopan R. (2003) Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu. Rev. Neurosci. 26, 565597.
  • Shirotani K., Tsubuki S., Iwata N. et al. (2001) Neprilysin degrades both amyloid β peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J. Biol. Chem. 276, 2189521901.
  • Sousa J. C., Cardoso I., Marques F., Saraiva M. J. and Palha J. A. (2006) Transthyretin and Alzheimer's disease: where in the brain? Neurobiol. Aging 28, 713718.
  • Stein T. D. and Johnson J. A. (2002) Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J. Neurosci. 22, 73807388.
  • Tsuzuki K., Fukatsu R., Yamaguchi H., Tateno M., Imai K., Fujii N. and Yamauchi T. (2000) Transthyretin binds amyloid β peptides, Aβ1-42 and Aβ1-40 to form complex in the autopsied human kidney - possible role of transthyretin for aβ sequestration. Neurosci. Lett. 281, 1711714.
  • Vázquez M. C., Vargas L. M., Inestrosa N. C. and Alvarez A. R. (2009) c-Abl modulates AICD dependent cellular responses: Transcriptional induction and apoptosis. J. Cell. Physiol. 220, 136143.
  • Vingtdeux V., Hamdane M., Begard S., Loyens A., Delacourte A., Beauvillain J. C., Buée L., Marambaud P. and Sergeant N. (2007a) Intracellular pH regulates amyloid precursor protein intracellular domain accumulation. Neurobiol. Dis. 25, 686696.
  • Vingtdeux V., Hamdane M., Loyens A. et al. (2007b) Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. J. Biol. Chem. 282, 1819718205.
  • Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S., Rowan M. J. and Selkoe D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535539.
  • Weidemann A., Eggert S., Reinhard F. B., Vogel M., Paliga K., Baier G., Masters C. L., Beyreuther K. and Evin G. (2002) A novel ε-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry 41, 28252835.
  • Yamada T., Sasaki H., Dohura K., Goto I. and Sakaki Y. (1989) Structure and expression of the alternatively-spliced forms of mRNA for the mouse homolog of Alzheimer's disease amyloid beta protein precursor. Biochem. Biophys. Res. Commun. 158, 906912.
  • Yasojima K., McGeer E. G. and McGeer P. L. (2001) Relationship between β amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain. Brain Res. 919, 115121.
  • Zhou F., Gong K., Song B., Ma T., van Laar T., Gong Y. and Zhang L. (2012) The APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth. Biochim. Biophys. Acta 1823, 12331241.
  • Zuccato C., Belyaev N., Conforti P. et al. (2007) Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. J. Neurosci. 27, 69726983.